PPD affects 1 in 7 new mothers — and many birthing parents and fathers too. It is not weakness. It is not failure. It is a medical condition with an effective, evidence-based treatment pathway.
After childbirth, estrogen and progesterone levels fall by as much as 100-fold within 24 hours — one of the most dramatic hormonal shifts the human body experiences. For many new mothers, this hormonal crash triggers a cascade of neurological changes: disrupted serotonin signalling, heightened stress reactivity, and dysregulation in the prefrontal circuits that govern mood, executive function, and emotional control.
Traditional treatments rely on antidepressants that may take weeks to work and carry concerns for breastfeeding mothers. TMS targets the neural source directly — no systemic medication, no waiting months for relief.
Transcranial Magnetic Stimulation uses precisely targeted magnetic pulses to reactivate mood-regulating brain circuits disrupted by the hormonal and neurological upheaval of childbirth — safely, without systemic medication.
Childbirth suppresses activity in the left dorsolateral prefrontal cortex — the brain’s mood regulator. TMS coils deliver focused magnetic pulses to this region, restoring the top-down emotional control that becomes impaired after birth.
Postpartum hormonal shifts hyperactivate the amygdala and HPA stress axis — keeping new mothers in a constant state of threat. TMS modulates this circuit, reducing hyperreactivity and restoring a calmer baseline neurological state.
Unlike antidepressants, TMS is entirely non-systemic. No medication enters the bloodstream, so there is no risk of transfer through breast milk. Sessions are 30 minutes with no sedation, no recovery time, and no impact on feeding schedules.
These are three distinct conditions requiring very different responses. Understanding which you are experiencing is the essential first step.
Affects up to 80% of new mothers. Mood swings, tearfulness, and anxiety in the first 1–2 weeks postpartum that resolve on their own. No treatment required beyond rest and support.
Persistent, worsening symptoms beyond two weeks. Impairs functioning, bonding, and quality of life. Requires clinical assessment and treatment — therapy, TMS, medication, or a combination.
Affects ~1–2 in 1,000 new mothers. Hallucinations, delusions, confusion, and rapid mood swings. A psychiatric emergency — seek immediate medical attention.
Designed around a new mother’s reality — flexible, efficient, and built to fit into the chaos of new parenthood.
of postpartum depression patients respond positively to TMS treatment
medication in the bloodstream — completely safe for breastfeeding mothers
minutes per session — fits within a single nap window, no recovery needed
cleared TMS technology with an established safety profile since 2008
Many mothers with PPD face a difficult dilemma: antidepressants may help, but concerns about breastfeeding, side effects, or the weeks-long wait for the medication to work make them reluctant to start. Others have tried SSRIs previously with limited results.
TMS offers a clinically validated alternative — working directly at the level of brain circuitry, with no systemic effects, no impact on feeding, and a response timeline that is typically faster than medication.
“TMS represents a compelling treatment option for postpartum depression, particularly for mothers who are breastfeeding or have had inadequate responses to antidepressants.” — Peer-reviewed clinical review, 2024
